Insulin signaling
Metabolism
Metabolic disease
Throughout the day, during and between meals, the body must continuously determine:
(1) how much glucose, fat, and cholesterol should be generated or eliminated, and (2) how to transport those molecules between tissues and fluids. Our lab investigates how insulin signaling controls these processes, and how they become disrupted in conditions like insulin resistance, diabetes, liver disease, and atherosclerosis.
We use molecular and cellular approaches, metabolomics, proteomics and phosphoproteomics, RNA sequencing, kinetics using tracers, primary cells and organoids, physiology, mouse models of disease, and human specimens.
#metabolism #cholesterol #bile-acids #lipids #glucose #insulin #diabetes #obesity #atherosclerosis #liver #gut
Publications
2024-2025
Beyond scratching the surface: a non-pruritogenic novel bile acid derivative that ameliorates cholestatic- and diet-induced liver injury
Haeusler RA and DeBosch BJ (2025)
Gastroenterology
Bile acid metabolism in type 2 diabetes mellitus
Cadena-Sandoval M and Haeusler RA (2025)
Nature Reviews Endocrinology
Hepatic stellate cells control liver zonation, size and functions via R-spondin 3
Sugimoto A, Saito Y, Wang G, Sun Q, yin C, Lee KH, Geng Y, Rajbhandari P, Hernandez C, Steffani M, Qie J, Savage T, Goyal DM, Ray KC, Neelakantan TV, Yin D, Melms J, Lehrich BM, Yasaka TM, Liu S, Oertel M, Lan T, Guillot A, Peiseler M, Filliol A, Kanzaki H, Fujiwara N, Ravi S, Izar B, Brosch M, Hampe J, Remotti H, Argemi J, Sun Z, Kendall TJ, Hoshida Y, Tacke F, Fallowfield JA, Blockley-Powell SK, Haeusler RA, Steinman JB, Pajvani UB, Monga SP, Bataller R, Masoodi M, Arpaia N, Lee YA, Stockwell BR, Augustin HG, Schwabe RF. (2025)
Nature
Unresolved alterations in bile acid composition and dyslipidemia in maternal and cord blood after ursodeoxycholic acid treatment for intrahepatic cholestasis of pregnancy
Basu S°, Običan S°, Bertaggia E, Staab H, Izquierdo MC, Gyamfi-Bannerman C, Haeusler RA. (2024)
Am J Physiol – Gastrointest Liver Physiol
FcRn-dependent IgG accumulation in adipose tissue unmasks obesity pathophysiology
Yu L, Yang YX, Gong Z, Wan Q, Du Y, Zhou Q, Xiao Y, Zahr T, Wang Z, Yu Z, Yang K, Geng J, Fried S, Li J, Haeusler RA, Leong KW, Bai L, Wu Y, Sun L, Wang P, Zhu BT, Wang L, Qiang L. (2024)
Cell Metabolism
miR-33 deletion in hepatocytes attenuates NAFLD-NASH-HCC progression
Fernández-Tussy P, Cardelo MP, Zhang H, Sun J, Price NL, Boutagy NE, Goedeke L, Cadena-Sandoval M, Xirouchaki CE, Brown W, Yang X, Pastor-Rojo O, Haeusler RA, Bennet AM, Tiganis T, Suárez Y, Fernández-Hernando C. (2024)
JCI Insight. 9: e168476
Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis
Savage TM, Fortson KT, de los Santos-Alexis K, Oliveras-Alsina A, Rouanne M, Rae SS, Gamarra JR, Shayya H, Kornberg A, Cavero R, Li F, Han A, Haeusler RA, Adam J, Schwabe RF, Arpaia N. (2024)
Immunity. 57: 303-318
Alteration of Serum Bile Acids in Amyotrophic Lateral Sclerosis
Lee I, Nandakumar R, Haeusler RA. (2024)
Lipids. 59: 85-91
2021-2023
Insulin sensitization by hepatic FoxO deletion is insufficient to lower atherosclerosis in mice
Izquierdo MC, Harris M, Shanmugarajah N, Zhong K, Ozcan L, Fredman G, Haeusler RA. (2023)
bioRxiv
MAD2-dependent insulin receptor endocytosis regulates metabolic homeostasis
Park J, Hall C, Hubbard B, LaMoia T, Gaspar R, Nasiri A, Li F, Zhang H, Kim J, Haeusler RA, Accili D, Shulman GI, Yu H, Choi E. (2023)
Diabetes 72: 1781-1794
2019
2018
microRNA-205-5p is a modulator of insulin sensitivity that inhibits FOXO function
Langlet F, Tarbier M, Haeusler RA, Camastra S, Ferrannini E, Friedlander MR, and Accili D (2018)
Molecular Metabolism 17: 49-60
2016-2017
2014-2015
2012-2013
2010-2011